This article showed the issues that arise when patents are persued for genes and gene isolation. In March, Judge Robert W. Sweet ruled Myriad Genegtics and the University of Utah's patent for two genes called BRCA1 and BRCA2, and an analysis performed on the genes to see if women carry mutations that predispose them to breast and ovarian cancers was invalid. It was ruled this way because genes are a part of nature and patents can not be placed on nature. It was argued that the patent was for isolated genes and it is still an ongoing case. Professors and government official do not see a positive future for patents on genes
the link below gives the roles and duties of the National Institute of Health
http://en.wikipedia.org/wiki/National_Institutes_of_Health
No comments:
Post a Comment